Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

800px-rhesus_macaque_macaca_mulatta_in_kinnarsani_ws_ap_w_img_5792

Gilead’s remdesivir significantly reduces COVID-19 symptoms in rhesus monkeys in NIH trial

April 20, 2020 Business Services, Medical Communications, Sales and Marketing COVID-19, Gilead, National Institutes of Health, coronavirus, remdesivir

A study from the National Institutes of Health has shed more light on the efficacy of Gilead’s promising antiviral therapy …
News
covid-19_testing

English COVID-19 cases to be tracked by ethnicity

April 20, 2020 Sales and Marketing African-Americans, BAME, COVID-19, coronavirus

Cases of coronavirus are set to be tracked by ethnicity in England following an announced government review. The governments have …
News
stock-incyte-01-shutter

Incyte’s Pemazyre becomes FDA’s first and only approved unresectable, advanced cholangiocarcinoma treatment

April 20, 2020 Sales and Marketing FDA, Incyte, pharma

The FDA has approved the United States’ first and only treatment for previously treated, unresectable locally advanced or metastatic cholangiocarcinoma, …
News
pillsss

Hydroxychloroquine fails COVID-19 clinical trial in France

April 20, 2020 Sales and Marketing COVID-19, chloroquine, coronavirus, hydroxychloroquine

The malaria treatment hydroxychloroquine is facing further scrutiny as a coronavirus treatment after failed trials in France. The most recent …
News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

April 17, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10

Hydroxychloroquine dominates the news as the potential COVID-19 treatment has gone through various trials. A Chinese study showed that the …
News
fda2outsideweb

FDA approves UroGen’s Jelmyto as first therapy for low-grade upper tract urothelial cancer

April 16, 2020 Sales and Marketing Cancer, FDA, Jelmyto, UroGen Pharma, pharma, urothelial cancer

The FDA has moved to authorise UroGen Pharma’s Jelmyto (mitomycin gel) in the US for the treatment of low-grade upper …
News
nhs_sign_8

Scottish Medicines Consortium approves new drugs in multiple sclerosis, ulcerative colitis and diabetes

April 15, 2020 Research and Development, Sales and Marketing Biogen, Fambyra, Janssen, NHS, Rimzoic, Sandoz, Sanofi, Scotland, Scottish Medicines Consortium, Stelara, Suliqua, pharma

Medical regulation must still continue even in a global pandemic, and the Scottish Medicines Consortium, (SMC) has ploughed on with …
News

Patient Experience: Living with type 1 diabetes

April 14, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, diabetes, feature, patient experience

23-year-old US student Madelyn Lazra recently graduated with a BA in Business Law and certification in International Business, and is …
Feature
cdc_coronavirus_0

Pharmafile.com’s weekly COVID-19 news round-up

April 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus

The world looks for a coronavirus cure as Inovio begins human trials for a vaccine while another vaccine is in …
News
dr_molk

Seres Therapeutics appoints Dr Lisa von Moltke as new Chief Medical Officer

April 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Dr Lisa von Moltke has left Aklermes and has joined Seres Therapeutics as its new Chief Medical Officer. Chief Executive …
Appointment
shutterstock_138095450

Circassia terminates AstraZeneca partnership in exchange for £150m debt settlement

April 9, 2020 Sales and Marketing AstraZeneca, Circassia, partnership, pharma, respiratory

Circassia Pharmaceuticals has announced its decision to break away from a partnership it forged with AstraZeneca UK back in 2017 …
News
shutterstock_273326141

Roche signs multi-billion dollar RNA-targeted drug discovery deal with Arrakis Therapeutics

April 9, 2020 Research and Development, Sales and Marketing Arrakis, Roche, partnership, pharma

Roche has signed a new partnership with Arrakis Therapeutics in a bid to drive discovery of RNA-targeted small molecule (rSM) …
News
90ten_team_photo

Envision Pharma Group acquires healthcare comms consultancy 90TEN

April 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 90TEN, Envision Pharma Group, pharma

Global healthcare communications consultancy 90TEN has been acquired by Envision Pharma Group, it has been revealed. 90TEN said that it …
News
mcintyre-headshot

Dr Maritza McIntyre appointed Chief Development Officer at StrideBio

April 8, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

StrideBio have announced the appointment of Maritza McIntyre Ph.D., as its first Chief Development Officer. The newly created role will …
Appointment
sage_logo

Sage Therapeutics to halve its total workforce in radical cost-cutting move

April 8, 2020 Research and Development, Sales and Marketing Sage Therapeutics, pharma, staff cuts

Sage Therapeutics has revealed a radical restructuring effort to cut costs and “enable the company to advance its corporate strategy …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025